THM Capital Advisory advises Thélème shareholders in its sale to the EDL group

THM Capital Advisory advised Thélème's shareholders in connection with the sale of the company to the EDL group.

This transaction is the first acquisition of EDL since its association with Abénex 18 months ago, and is part of a development strategy aimed at extending the group's offer to other specialties and regions, with the ambition of becoming a European leader in medical imaging.

Thélème is a publisher of software solutions dedicated in particular to the management of nuclear medicine facilities. Thanks to this acquisition, EDL significantly strengthens its positioning in software dedicated to nuclear medicine in France and has development prospects abroad.

Thélème's teams have significant know-how and around 25 years of experience, enriching the range of skills of the EDL group. Thélème is recognized for its technical expertise and the quality of its customer service, and the complementarity of customers should allow the two players to strengthen their respective positions.

The transaction also opens up new growth prospects for Thélème in the public sector in France and Belgium.

Alain Lopez and Frédéric Camboulives, respectively President and CEO of the EDL Group, declare:

“The acquisition of Thélème is an important step in order to strengthen our position in nuclear medicine in France and to enter new foreign markets. We are very happy to welcome Thélème's teams to EDL who will strengthen the Group's technological skills.”

Jérôme Vandermarcq, Partner at Abénex, states:

“This acquisition is fully integrated into EDL's development strategy built with its managers when we acquired a stake in 2021 (...) Other potential acquisitions currently under consideration are part of this consolidation process.”

THM Capital Advisory advised the sellers as financial advisor (Thomas Mitard, Aurélien Prost).